menu toggle
Contact Us
About us
Who we are
Our global reach
Gallery of innovation
Expertise
Why Xcenda?
Areas of expertise
Solutions
Commercialization solutions
Innovative field solutions
Health economics & outcomes research
Reimbursement & policy insights
Real-world evidence
FormularyDecisions
Value and access communications
Global market access consulting
Product launch and commercialization
Market research and advisor networks
Training & learning solutions
Manufacturer solutions from AmerisourceBergen
Our people
Our team
Insights
Insights home
Health Policy Weekly archive
HTA Quarterly archive
Careers
Careers
Life at Xcenda
Student programs
Search for jobs
The AmerisourceBergen network
News and events
Locations
Subscribe to newsletters
Contact us
LinkedIn
X
Instagram
About us
Who we are
Our global reach
Gallery of innovation
Expertise
Why Xcenda?
Areas of expertise
Solutions
Commercialization solutions
Innovative field solutions
Health economics & outcomes research
Reimbursement & policy insights
Real-world evidence
FormularyDecisions
Value and access communications
Global market access consulting
Product launch and commercialization
Market research and advisor networks
Training & learning solutions
Manufacturer solutions from AmerisourceBergen
Our people
Our team
Insights
Insights home
Health Policy Weekly archive
HTA Quarterly archive
Careers
Careers
Life at Xcenda
Student programs
Search for jobs
The AmerisourceBergen network
News and events
Locations
Subscribe to newsletters
Contact us
LinkedIn
X
Instagram
Insights
Filter By
All Topics
340B
Advocacy
Affordability
Analytics
Biosimilars
Business performance
Cell and gene therapy
Clinical trial logistics
Commercial supply chain
Commercialization
Consulting
COVID-19
Data
Direct-to-patient
Distribution
Engagement
Field Support
Financial management
Formulary solutions
Health equity
Innovation
Legislation
Managed care
Market access
Marketing
Medication adherence
Medication therapy management
Oncology
Orphan drugs
Our role in healthcare
Patient care
Patient support services
Policy
Population health management
Product access
Quality
Regulatory
Reimbursement
Research
Specialty pharmacy
Technology
Value-based care
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
Xcenda
Medicare cannot age in place: A diversifying population requires policy evolution
Xcenda
March 2023
340B – A missed opportunity to address those that are medically underserved
Xcenda
November 2021
Equity considerations in US value assessment: Opportunities ahead
Xcenda
August 2021
